Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1391 ARTÍCULOS , VIENDO DEL 1321 AL 1335

The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease

Dursun E, Gezen-Ak D, Hanağası H, Bilgiç B, Lohmann E, Ertan S, Atasoy İL, Alaylıoğlu M, Araz ÖS, Önal B, Gündüz A, Apaydın H, Kızıltan G, Ulutin T, Gürvit H, Yılmazer S.

J Neuroimmunol. 2015 Jun 15;283:50-7. doi: 10.1016/j.jneuroim.2015.04.014. Epub 2015 Apr 25.

Neuroimaging correlates of cognitive impairment and dementia in Parkinson's disease

Mak E, Su L, Williams GB, O'Brien JT.

Parkinsonism Relat Disord. 2015 Aug;21(8):862-70. doi: 10.1016/j.parkreldis.2015.05.013. Epub 2015 May 19.

The relationship between atrophy and hypometabolism: is it regionally dependent in dementias?

Rodriguez-Oroz MC, Gago B, Clavero P, Delgado-Alvarado M, Garcia-Garcia D, Jimenez-Urbieta H.

Curr Neurol Neurosci Rep. 2015 Jul;15(7):44. doi: 10.1007/s11910-015-0562-0.

Increased Risk of Dementia in Patients With Chronic Obstructive Pulmonary Disease

Liao KM, Ho CH, Ko SC, Li CY.

Medicine (Baltimore). 2015 Jun;94(23):e930. doi: 10.1097/MD.0000000000000930.

Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases

Fernández-Moriano C, González-Burgos E, Gómez-Serranillos MP.

Oxid Med Cell Longev. 2015;2015:408927. doi: 10.1155/2015/408927. Epub 2015 Apr 29.

Oculo-visual changes and clinical considerations affecting older patients with dementia

Armstrong R, Kergoat H.

Ophthalmic Physiol Opt. 2015 Jul;35(4):352-76. doi: 10.1111/opo.12220.

Is early-life iron exposure critical in neurodegeneration?

Hare DJ, Arora M, Jenkins NL, Finkelstein DI, Doble PA, Bush AI.

Nat Rev Neurol. 2015 Sep;11(9):536-44. doi: 10.1038/nrneurol.2015.100. Epub 2015 Jun 23.

Neuroimaging signature of neuropsychiatric disorders

Worbe Y.

Curr Opin Neurol. 2015 Aug;28(4):358-64. doi: 10.1097/WCO.0000000000000220.

Why bother using non-human primate models of cognitive disorders in translational research?

Camus S, Ko WK, Pioli E, Bezard E.

Neurobiol Learn Mem. 2015 Oct;124:123-9. doi: 10.1016/j.nlm.2015.06.012. Epub 2015 Jun 29.

Can clock drawing differentiate Alzheimer's disease from other dementias?

Tan LP, Herrmann N, Mainland BJ, Shulman K.

Int Psychogeriatr. 2015 Oct;27(10):1649-60. doi: 10.1017/S1041610215000939. Epub 2015 Jul 3.

[FALLS IN PATIENTS WITH DEMENTIA]

Aizen E.

Harefuah. 2015 May;154(5):323-6, 338.

Identifying the components of clinical vignettes describing Alzheimer's disease or other dementias: a scoping review

Randhawa H, Jiwa A, Oremus M.

BMC Med Inform Decis Mak. 2015 Jul 15;15:54. doi: 10.1186/s12911-015-0179-x.

Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Donohue MC, Green RC, Harvey D, Jack CR Jr, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw L, Thompson PM, Toga AW, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Jul;11(7):865-84. doi: 10.1016/j.jalz.2015.04.005.

Mutations in presenilin 2 and its implications in Alzheimer's disease and other dementia-associated disorders

Cai Y, An SS, Kim S.

Clin Interv Aging. 2015 Jul 14;10:1163-72. doi: 10.2147/CIA.S85808. eCollection 2015.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias